Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.36B | 1.71B | 1.64B | 741.00M | 1.68B | 541.00M |
Gross Profit | 1.45B | 940.00M | 1.73B | 741.00M | 1.82B | 185.00M |
EBITDA | 1.86B | 2.32B | 2.12B | 1.16B | 1.60B | 823.00M |
Net Income | 1.46B | 1.52B | 1.52B | 600.00M | 1.57B | 484.00M |
Balance Sheet | ||||||
Total Assets | 29.07B | 28.25B | 23.80B | 22.40B | 20.84B | 16.20B |
Cash, Cash Equivalents and Short-Term Investments | 447.00M | 635.00M | 535.00M | 303.00M | 372.00M | 254.00M |
Total Debt | 0.00 | 13.76B | 11.94B | 12.32B | 11.14B | 8.55B |
Total Liabilities | 15.04B | 14.90B | 12.60B | 12.84B | 11.97B | 9.02B |
Stockholders Equity | 14.03B | 13.36B | 11.20B | 9.55B | 8.87B | 7.18B |
Cash Flow | ||||||
Free Cash Flow | 1.28B | 1.28B | 1.00B | 746.00M | 935.00M | 734.00M |
Operating Cash Flow | 1.28B | 1.28B | 1.00B | 746.00M | 935.00M | 734.00M |
Investing Cash Flow | -2.58B | -3.41B | -489.00M | -2.10B | -3.39B | -1.29B |
Financing Cash Flow | 1.29B | 2.42B | -284.00M | 1.21B | 2.62B | 707.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $14.38B | 9.86 | 10.25% | 9.53% | 7.71% | -29.47% | |
74 Outperform | $5.62B | 10.35 | 19.65% | 6.17% | 28.32% | 13.63% | |
71 Outperform | $3.66B | 9.71 | 9.33% | 11.93% | 32.19% | -13.72% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
63 Neutral | $21.30B | ― | 2.55% | 3.26% | 43.48% | -24.02% | |
58 Neutral | $4.29B | 19.04 | 3.39% | 18.72% | -8.32% | -65.56% | |
57 Neutral | $3.41B | 12.34 | 12.81% | 10.27% | -15.88% | -13.91% |
On September 9, 2025, Ares Capital Corporation entered into a Fourth Supplemental Indenture with U.S. Bank Trust Company to issue $650 million in 5.100% notes due 2031. The proceeds from this issuance are intended to repay existing debt, with the potential for reborrowing for general corporate purposes, including investments in portfolio companies. The transaction also involved a forward-starting interest rate swap to transition from a fixed to a floating interest rate, effective from July 15, 2026.
The most recent analyst rating on (ARCC) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Ares Capital stock, see the ARCC Stock Forecast page.
On August 8, 2025, Ares Capital Corporation held a special meeting of stockholders where a proposal was approved to allow the company to sell or issue shares of its common stock at a price below its current net asset value per share, subject to certain limitations. This authorization, which includes a cap that the number of shares issued does not exceed 25% of its outstanding shares, will be effective for a twelve-month period ending on August 8, 2026.
The most recent analyst rating on (ARCC) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Ares Capital stock, see the ARCC Stock Forecast page.